Literature DB >> 12688544

Intra-aortic balloon pumping in acute mitral regurgitation reduces aortic impedance and regurgitant fraction.

André L A J Dekker1, Koen D Reesink, Frederik H van der Veen, G Vincent A van Ommen, Gijs G Geskes, A Cecilia M Soemers, Jos G Maessen.   

Abstract

Acute mitral regurgitation (MR) is present in 10% of patients presenting with cardiogenic shock. To stabilize these patients, intra-aortic balloon pumping (IABP) is recommended, but the mechanism of IABP support in these patients is unknown. This animal study was designed to describe the hemodynamic effect of intra-aortic balloon pumping during cardiogenic shock induced by acute MR. In eight calves, left ventricular pressure-volume loops, aortic and left atrial pressure, and aortic, carotid artery, and coronary blood flow were recorded. Acute MR (range 36%-79%) was created by placing a metal cage in the mitral valve. Hemodynamic data was obtained at control, during acute MR, and during acute MR with 1:1 IABP support. Acute MR caused a decrease in cardiac output (-32%, P = 0.018), blood pressure, and carotid artery flow, whereas left ventricular output (+127%, P = 0.018), end-diastolic volume, and left atrial pressure all significantly increased. Stroke work, ejection fraction, and coronary blood flow were not significantly changed, and no signs of ischemia were seen on the ECG. The IABP raised average cardiac output by 31% (P = 0.012) and significantly raised blood pressure and flow to the brain while decreasing systemic vascular resistance. Left ventricular function and mean coronary blood flow did not change, but diastolic coronary flow became more important as shown by the increase in diastolic fraction from 64% to 95%. (P = 0.028). Average MR dropped by 7.5% (P = 0.025). In conclusion, application of the IABP during acute MR lowers aortic impedance, resulting in less MR and more output toward the aorta without changing left ventricular function.

Entities:  

Mesh:

Year:  2003        PMID: 12688544     DOI: 10.1097/00024382-200304000-00007

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

Review 1.  Pre- and post-operative mechanical circulatory support in surgical repair of post-acute myocardial infarction mechanical complications.

Authors:  Anju Bhardwaj; Sachin Kumar; Ismael A Salas de Armas; Angelo Nascimbene; Sriram Nathan; Biswajit Kar; Igor D Gregoric
Journal:  Ann Cardiothorac Surg       Date:  2022-05

2.  Cardiogenic shock with stunned myocardium during triple-H therapy treated with intra-aortic balloon pump counterpulsation.

Authors:  Fabio Silvio Taccone; Boris Lubicz; Michael Piagnerelli; Marc Van Nuffelen; Jean-Louis Vincent; Daniel De Backer
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

3.  Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation.

Authors:  Andrea Rossi; Stefano Bonapace; Mariantonietta Cicoira; Luca Conte; Anna Anselmi; Corrado Vassanelli
Journal:  Heart Vessels       Date:  2012-10-13       Impact factor: 2.037

4.  Emergent TandemHeart-ECMO for acute severe mitral regurgitation with cardiogenic shock and hypoxaemia: a case series.

Authors:  Michael DiVita; Gautam K Visveswaran; Kasaiah Makam; Peyman Naji; Marc Cohen; Saurabh Kapoor; Craig R Saunders; Mark J Zucker
Journal:  Eur Heart J Case Rep       Date:  2020-01-06

Review 5.  Acute Ischaemic Mitral Valve Regurgitation.

Authors:  Breda Hennessey; Nestor Sabatovicz; Maria Del Trigo
Journal:  J Clin Med       Date:  2022-09-21       Impact factor: 4.964

6.  Computational prediction of the effects of the intra-aortic balloon pump on heart failure with valvular regurgitation using a 3D cardiac electromechanical model.

Authors:  Chang-Hyun Kim; Kwang-Soup Song; Natalia A Trayanova; Ki Moo Lim
Journal:  Med Biol Eng Comput       Date:  2017-10-23       Impact factor: 2.602

Review 7.  Vascular phenotypes of acute decompensated vs. new-onset heart failure: treatment implications.

Authors:  Jorge Ferreira
Journal:  ESC Heart Fail       Date:  2017-09-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.